116 related articles for article (PubMed ID: 1408797)
1. Lability of monofunctional cis-platinum adducts: role of DNA double helix.
Anin MF; Gaucheron F; Leng M
Nucleic Acids Res; 1992 Sep; 20(18):4825-30. PubMed ID: 1408797
[TBL] [Abstract][Full Text] [Related]
2. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
Payet D; Gaucheron F; Sip M; Leng M
Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
[TBL] [Abstract][Full Text] [Related]
3. Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.
Gaucheron F; Malinge JM; Blacker AJ; Lehn JM; Leng M
Proc Natl Acad Sci U S A; 1991 May; 88(9):3516-9. PubMed ID: 2023897
[TBL] [Abstract][Full Text] [Related]
4. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
[TBL] [Abstract][Full Text] [Related]
5. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
[TBL] [Abstract][Full Text] [Related]
6. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
[TBL] [Abstract][Full Text] [Related]
7. Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: relation with the clinical inefficiency of transplatin.
Boudvillain M; Dalbiès R; Aussourd C; Leng M
Nucleic Acids Res; 1995 Jul; 23(13):2381-8. PubMed ID: 7630715
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases.
Corda Y; Job C; Anin MF; Leng M; Job D
Biochemistry; 1993 Aug; 32(33):8582-8. PubMed ID: 7689335
[TBL] [Abstract][Full Text] [Related]
10. Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.
Malinge JM; Sip M; Blacker AJ; Lehn JM; Leng M
Nucleic Acids Res; 1990 Jul; 18(13):3887-91. PubMed ID: 2374713
[TBL] [Abstract][Full Text] [Related]
11. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
Pérez C; Leng M; Malinge JM
Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
[TBL] [Abstract][Full Text] [Related]
12. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V
J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of trans-[Pt(NH3)2Cl2] adducts of d(CCTCGAGTCTCC).d(GGAGACTCGAGG).
Lepre CA; Chassot L; Costello CE; Lippard SJ
Biochemistry; 1990 Jan; 29(3):811-23. PubMed ID: 2159792
[TBL] [Abstract][Full Text] [Related]
14. DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.
Brabec V; Leng M
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5345-9. PubMed ID: 8506383
[TBL] [Abstract][Full Text] [Related]
15. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
Corda Y; Anin MF; Leng M; Job D
Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
[TBL] [Abstract][Full Text] [Related]
16. Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.
Bellon SF; Lippard SJ
Biophys Chem; 1990 Apr; 35(2-3):179-88. PubMed ID: 2397272
[TBL] [Abstract][Full Text] [Related]
17. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
19. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
Reed E; Gupta-Burt S; Litterst CL; Poirier MC
Carcinogenesis; 1990 Dec; 11(12):2117-21. PubMed ID: 1979937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]